Elejalde syndrome: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
[[File:Autosomal_recessive_-_en.svg| | | name = Elejalde syndrome | ||
| image = [[File:Autosomal_recessive_-_en.svg|200px]] | |||
| caption = Elejalde syndrome is inherited in an [[autosomal recessive]] pattern. | |||
| synonyms = Neuroectodermal melanolysosomal disease | |||
| field = [[Medical genetics]] | |||
| symptoms = [[Hypopigmentation]], [[neurological abnormalities]], [[developmental delay]] | |||
| onset = [[Infancy]] | |||
| duration = Lifelong | |||
| causes = [[Genetic mutation]] | |||
| risks = Family history of the condition | |||
| diagnosis = [[Genetic testing]], [[clinical evaluation]] | |||
| differential = [[Chediak-Higashi syndrome]], [[Griscelli syndrome]] | |||
| treatment = Symptomatic and supportive care | |||
| prognosis = Variable, often poor | |||
| frequency = Rare | |||
}} | |||
'''Elejalde syndrome''', also known as '''neuroectodermal melanolysosomal disease''', is a rare [[genetic disorder]] characterized by a combination of [[neurological]], [[dermatological]], and [[ocular]] abnormalities. It is an [[autosomal recessive]] condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. | '''Elejalde syndrome''', also known as '''neuroectodermal melanolysosomal disease''', is a rare [[genetic disorder]] characterized by a combination of [[neurological]], [[dermatological]], and [[ocular]] abnormalities. It is an [[autosomal recessive]] condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. | ||
== Clinical Features == | == Clinical Features == | ||
Individuals with Elejalde syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include: | Individuals with Elejalde syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include: | ||
* '''Neurological abnormalities''': These may include [[developmental delay]], [[intellectual disability]], and [[seizures]]. | * '''Neurological abnormalities''': These may include [[developmental delay]], [[intellectual disability]], and [[seizures]]. | ||
* '''Dermatological features''': Patients often have [[hypopigmentation]] of the skin and hair, leading to a lighter appearance compared to unaffected family members. | * '''Dermatological features''': Patients often have [[hypopigmentation]] of the skin and hair, leading to a lighter appearance compared to unaffected family members. | ||
* '''Ocular abnormalities''': These can include [[nystagmus]], [[strabismus]], and other vision problems. | * '''Ocular abnormalities''': These can include [[nystagmus]], [[strabismus]], and other vision problems. | ||
== Pathophysiology == | == Pathophysiology == | ||
Elejalde syndrome is caused by mutations in genes involved in the development and function of [[melanosomes]], which are specialized organelles responsible for the production and storage of [[melanin]]. The exact genetic mutations responsible for Elejalde syndrome have not been fully elucidated, but they are believed to affect the [[lysosomal]] and [[melanosomal]] pathways. | Elejalde syndrome is caused by mutations in genes involved in the development and function of [[melanosomes]], which are specialized organelles responsible for the production and storage of [[melanin]]. The exact genetic mutations responsible for Elejalde syndrome have not been fully elucidated, but they are believed to affect the [[lysosomal]] and [[melanosomal]] pathways. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of Elejalde syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes. Differential diagnosis may include other conditions with similar presentations, such as [[Chediak-Higashi syndrome]] and [[Griscelli syndrome]]. | Diagnosis of Elejalde syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes. Differential diagnosis may include other conditions with similar presentations, such as [[Chediak-Higashi syndrome]] and [[Griscelli syndrome]]. | ||
== Management == | == Management == | ||
There is currently no cure for Elejalde syndrome, and treatment is primarily supportive. Management strategies may include: | There is currently no cure for Elejalde syndrome, and treatment is primarily supportive. Management strategies may include: | ||
* '''Neurological care''': Anticonvulsant medications may be used to control seizures. | * '''Neurological care''': Anticonvulsant medications may be used to control seizures. | ||
* '''Dermatological care''': Sun protection and skin care may be recommended to manage hypopigmentation. | * '''Dermatological care''': Sun protection and skin care may be recommended to manage hypopigmentation. | ||
* '''Ophthalmological care''': Regular eye examinations and corrective lenses may be necessary to address vision problems. | * '''Ophthalmological care''': Regular eye examinations and corrective lenses may be necessary to address vision problems. | ||
== Genetic Counseling == | == Genetic Counseling == | ||
[[Genetic counseling]] is recommended for families affected by Elejalde syndrome. As an autosomal recessive disorder, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Carrier testing and prenatal diagnosis may be options for at-risk families. | [[Genetic counseling]] is recommended for families affected by Elejalde syndrome. As an autosomal recessive disorder, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Carrier testing and prenatal diagnosis may be options for at-risk families. | ||
== See also == | |||
== | |||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
* [[Autosomal recessive]] | * [[Autosomal recessive]] | ||
| Line 41: | Line 42: | ||
* [[Chediak-Higashi syndrome]] | * [[Chediak-Higashi syndrome]] | ||
* [[Griscelli syndrome]] | * [[Griscelli syndrome]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
Latest revision as of 14:48, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Elejalde syndrome | |
|---|---|
| |
| Synonyms | Neuroectodermal melanolysosomal disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypopigmentation, neurological abnormalities, developmental delay |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Chediak-Higashi syndrome, Griscelli syndrome |
| Prevention | N/A |
| Treatment | Symptomatic and supportive care |
| Medication | N/A |
| Prognosis | Variable, often poor |
| Frequency | Rare |
| Deaths | N/A |
Elejalde syndrome, also known as neuroectodermal melanolysosomal disease, is a rare genetic disorder characterized by a combination of neurological, dermatological, and ocular abnormalities. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.
Clinical Features[edit]
Individuals with Elejalde syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:
- Neurological abnormalities: These may include developmental delay, intellectual disability, and seizures.
- Dermatological features: Patients often have hypopigmentation of the skin and hair, leading to a lighter appearance compared to unaffected family members.
- Ocular abnormalities: These can include nystagmus, strabismus, and other vision problems.
Pathophysiology[edit]
Elejalde syndrome is caused by mutations in genes involved in the development and function of melanosomes, which are specialized organelles responsible for the production and storage of melanin. The exact genetic mutations responsible for Elejalde syndrome have not been fully elucidated, but they are believed to affect the lysosomal and melanosomal pathways.
Diagnosis[edit]
Diagnosis of Elejalde syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes. Differential diagnosis may include other conditions with similar presentations, such as Chediak-Higashi syndrome and Griscelli syndrome.
Management[edit]
There is currently no cure for Elejalde syndrome, and treatment is primarily supportive. Management strategies may include:
- Neurological care: Anticonvulsant medications may be used to control seizures.
- Dermatological care: Sun protection and skin care may be recommended to manage hypopigmentation.
- Ophthalmological care: Regular eye examinations and corrective lenses may be necessary to address vision problems.
Genetic Counseling[edit]
Genetic counseling is recommended for families affected by Elejalde syndrome. As an autosomal recessive disorder, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Carrier testing and prenatal diagnosis may be options for at-risk families.
